Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Structural dynamics associated with intermediate formation in an archetypal conformational disease.

Nyon M.P., Segu L., Cabrita L.D., Levy G.R., Kirkpatrick J., Roussel B.D., Patschull A.O., Barrett T.E., Ekeowa U.I., Kerr R., Waudby C.A., Kalsheker N., Hill M., Thalassinos K., Lomas D.A., Christodoulou J., Gooptu B.

In conformational diseases, native protein conformers convert to pathological intermediates that polymerize. Structural characterization of these key intermediates is challenging. They are unstable and minimally populated in dynamic equilibria that may be perturbed by many analytical techniques. We have characterized a forme fruste deficiency variant of α(1)-antitrypsin (Lys154Asn) that forms polymers recapitulating the conformer-specific neo-epitope observed in polymers that form in vivo. Lys154Asn α(1)-antitrypsin populates an intermediate ensemble along the polymerization pathway at physiological temperatures. Nuclear magnetic resonance spectroscopy was used to report the structural and dynamic changes associated with this. Our data highlight an interaction network likely to regulate conformational change and do not support the recent contention that the disease-relevant intermediate is substantially unfolded. Conformational disease intermediates may best be defined using powerful but minimally perturbing techniques, mild disease mutants, and physiological conditions.

Structure 20:504-512(2012) [PubMed] [Europe PMC]

UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again